Fever News and Research

RSS

New blueberry-sized ingestible sensor tracks internal body temperature

In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect the core body temperature.

15 Jun 2026

Australia’s diphtheria outbreak shows why boosters, antibiotics, and better housing all matter

A 131-case diphtheria outbreak in Australia’s Northern Territory showed how toxigenic Corynebacterium diphtheriae can re-emerge even in highly vaccinated populations. Genomic and epidemiological evidence linked most cases to a dominant ST381 strain, with transmission shaped by overcrowding, poor skin health, and persistent health inequities.

15 Jun 2026

Key proteins enable louse-borne relapsing fever pathogen to evade immunity

Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice).

10 Jun 2026

Study finds indoor cats do not trigger child asthma flares

Asthma is the most common chronic disease and one of the main causes of hospitalization among children. The Global Asthma Network has estimated that its global prevalence is 9.1% for children and 11.0% for adolescents, but this percentage varies greatly between countries, regions, and environments.

10 Jun 2026

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Universal Sarbeco coronavirus vaccine proves safe in first human trial

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects.

4 Jun 2026

New data confirms dengue vaccine safety for older and chronic-risk travelers

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.

4 Jun 2026

New all-oral regimen improves treatment convenience for AML patients

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.

3 Jun 2026

Study finds serious blood-related side effects associated with antibody-drug conjugates

A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies.

2 Jun 2026

New T-cell engager therapy shows effectiveness in advanced solid tumors

A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors.

1 Jun 2026

Climate change could expand chikungunya into temperate regions worldwide

Chikungunya ('to become contorted' in the Kimakonde language, named after the characteristic joint ache) is classified as one of the neglected tropical diseases by the World Health Organization.

27 May 2026

New AI tools identify potential drugs for rare Ebola virus

Recent advances in artificial intelligence have enabled Southwest Research Institute (SwRI) to identify nearly two dozen antiviral compounds that could potentially treat a rare species of Ebola virus (Bundibugyo virus) currently affecting the Democratic Republic of Congo.

26 May 2026

How a tiny H5N1 dose triggers massive virus shedding in cow milk

Experimental infection studies in lactating Holstein cows showed that H5N1 B3.13 can infect the bovine mammary gland at doses as low as 10 TCID50, producing extremely high viral loads in milk. However, the virus did not transmit to sentinel cows through repeated exposure to contaminated milking equipment or through close contact under high-biocontainment conditions, suggesting that real-world dairy-farm spread depends on additional cofactors.

25 May 2026

New vaccine approach targets broad protection against arenavirus infections

Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine.

21 May 2026

Researchers track genetic changes in Brazil's rare Sabiá virus

The Sabiá virus causes an acute hemorrhagic and neurological syndrome. Four fatal cases have been recorded in the state of São Paulo since 1990.

20 May 2026

Severe asthma patients often face multiple overlooked health conditions

Most people living with severe asthma are also battling other health conditions that go under the radar, a major new study has found.

20 May 2026

Neutrophils may play unexpected role in schizophrenia development

The most common white blood cells in your body - immune cells called neutrophils - can make a protein nobody knew they were making, Stanford Medicine investigators have discovered.

19 May 2026

Climate change drives emerging vector-borne diseases in Canada

Climate change is affecting the local ecology in Canada, contributing to emerging tick- and mosquito-borne diseases and infections in humans, argue authors of a commentary published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260668.

19 May 2026

Bundibugyo virus outbreak triggers international public health emergency declaration

Pursuant to paragraph 2 of Article 12 - Determination of a public health emergency of international concern, including a pandemic emergency of the International Health Regulations (2005) (IHR), the Director-General of the World Health Organization (WHO), after having consulted the States Parties where the event is known to be currently occurring, is hereby determining that the Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda constitutes a public health emergency of international concern (PHEIC), but does not meet the criteria of pandemic emergency, as defined in the IHR.

18 May 2026